Point72 Asia Singapore Pte. Ltd. Has $51,000 Stock Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Point72 Asia Singapore Pte. Ltd. reduced its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 55.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,031 shares of the company’s stock after selling 3,745 shares during the period. Point72 Asia Singapore Pte. Ltd.’s holdings in Phibro Animal Health were worth $51,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of PAHC. CWM LLC grew its position in Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after acquiring an additional 1,035 shares during the period. Fidelis Capital Partners LLC bought a new stake in Phibro Animal Health in the 1st quarter valued at $46,000. China Universal Asset Management Co. Ltd. lifted its holdings in shares of Phibro Animal Health by 65.0% in the first quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after purchasing an additional 1,531 shares in the last quarter. Summit Securities Group LLC acquired a new stake in shares of Phibro Animal Health in the second quarter valued at approximately $83,000. Finally, Illinois Municipal Retirement Fund lifted its position in Phibro Animal Health by 7.2% during the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after buying an additional 765 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Stock Performance

Shares of Phibro Animal Health stock opened at $22.52 on Tuesday. The company has a quick ratio of 1.64, a current ratio of 2.94 and a debt-to-equity ratio of 1.79. The business has a 50 day moving average price of $19.75 and a 200-day moving average price of $17.26. Phibro Animal Health Co. has a 52 week low of $9.40 and a 52 week high of $22.84. The company has a market cap of $912.13 million, a PE ratio of 70.38, a price-to-earnings-growth ratio of 1.77 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. The firm had revenue of $273.16 million for the quarter, compared to analysts’ expectations of $262.44 million. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. Equities analysts anticipate that Phibro Animal Health Co. will post 1.44 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th were paid a $0.12 dividend. The ex-dividend date was Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.13%. Phibro Animal Health’s dividend payout ratio is presently 150.00%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on PAHC shares. Bank of America upped their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price on the stock. Three analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $15.00.

Insider Activity at Phibro Animal Health

In other news, Director E Thomas Corcoran purchased 5,000 shares of the business’s stock in a transaction on Wednesday, September 4th. The shares were acquired at an average price of $20.02 per share, with a total value of $100,100.00. Following the acquisition, the director now directly owns 25,000 shares in the company, valued at $500,500. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 50.06% of the stock is currently owned by insiders.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.